MarketCap
Facebook
X
TelegramQuartalsbericht 2023-Q3
hinzugefügt 23.05.2026
Invitae Corporation Anteile 2011-2026 | NVTA
Anteile Jährlich Invitae Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 236 M | 211 M | 135 M | 90.9 M | 66.7 M | 46.5 M | 33.2 M | 28.2 M | 846 K | 692 K | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 236 M | 692 K | 84.8 M |
Anteile Vierteljährlich Invitae Corporation
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 276 M | 264 M | 250 M | - | 238 M | 232 M | 228 M | 228 M | 218 M | 204 M | 194 M | 186 M | 132 M | 129 M | 99.6 M | 98.8 M | 95.6 M | 90.9 M | 79.4 M | 75.5 M | 70.2 M | 67.8 M | 54.4 M | 53.6 M | 48.2 M | 43.2 M | 42.3 M | 41.1 M | 32.3 M | 32.2 M | 32 M | 31.9 M | 31.9 M | 31.8 M | 17.1 M | 945 K | 886 K | 823 K | 749 K | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 276 M | 749 K | 104 M |
Anteile anderer Aktien in der Diagnostik & Forschung
| Name | Anteile | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
111 M | $ 203.59 | -0.44 % | $ 22.6 B | USA |
 |
Celcuity
CELC
|
46.8 M | $ 88.87 | -4.02 % | $ 4.16 B | USA |
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
1.33 M | $ 4.25 | -5.56 % | $ 5.65 M | USA |
 |
Castle Biosciences
CSTL
|
29 M | $ 21.19 | 0.52 % | $ 614 M | USA |
 |
Fulgent Genetics
FLGT
|
30.8 M | $ 19.02 | 2.84 % | $ 585 M | USA |
 |
Aspira Women's Health
AWH
|
34.1 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
23.3 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | USA |
 |
ICON Public Limited Company
ICLR
|
78.4 M | $ 147.15 | -3.08 % | $ 11.5 B |  Irlanda |
 |
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M |  Britain |
 |
Guardant Health
GH
|
125 M | $ 130.83 | 0.55 % | $ 16.4 B | USA |
 |
Illumina
ILMN
|
155 M | $ 164.1 | 2.54 % | $ 25.4 B | USA |
 |
CareDx, Inc
CDNA
|
53.3 M | $ 23.71 | 4.22 % | $ 1.26 B | USA |
 |
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
6.23 M | - | - | $ 9.42 M |  Israel |
 |
Interpace Biosciences
IDXG
|
4.42 M | $ 1.76 | 1.32 % | $ 7.79 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
132 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
464 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
67.5 M | $ 101.96 | 1.98 % | $ 6.88 B | USA |
 |
Charles River Laboratories International
CRL
|
49.6 M | $ 187.54 | -1.29 % | $ 9.3 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | USA |
 |
Pacific Biosciences of California
PACB
|
300 M | $ 1.4 | 1.82 % | $ 420 M | USA |
 |
Medpace Holdings
MEDP
|
28.8 M | $ 470.7 | 0.84 % | $ 13.6 B | USA |
 |
Exact Sciences Corporation
EXAS
|
189 M | - | - | $ 19.8 B | USA |
 |
Mettler-Toledo International
MTD
|
20.6 M | $ 1 132.35 | -2.63 % | $ 23.3 B |  Schweiz |
 |
NeoGenomics
NEO
|
128 M | $ 11.47 | 0.26 % | $ 1.47 B | USA |
 |
Myriad Genetics
MYGN
|
92.6 M | $ 4.59 | 0.99 % | $ 425 M | USA |
 |
National Research Corporation
NRC
|
22.4 M | $ 21.0 | 6.33 % | $ 470 M | USA |
 |
Natera
NTRA
|
137 M | $ 218.38 | -1.99 % | $ 29.9 B | USA |
 |
Personalis
PSNL
|
89.2 M | $ 9.74 | -0.1 % | $ 869 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
948 M | $ 25.77 | -2.77 % | $ 24.4 B |  Niderland |
 |
Senseonics Holdings
SENS
|
41.7 M | $ 7.22 | -2.83 % | $ 301 M | USA |
 |
QIAGEN N.V.
QGEN
|
217 M | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
50.8 M | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
2.3 M | $ 2.03 | -1.02 % | $ 4.66 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
83.2 M | $ 268.15 | -1.12 % | $ 22.3 B | USA |
 |
Twist Bioscience Corporation
TWST
|
59.8 M | $ 68.37 | -2.41 % | $ 4.09 B | USA |
 |
Thermo Fisher Scientific
TMO
|
377 M | $ 482.91 | -2.31 % | $ 182 B | USA |
 |
Trinity Biotech plc
TRIB
|
359 M | $ 0.68 | 2.39 % | $ 244 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
1.55 M | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
217 M | $ 9.26 | -0.32 % | $ 2.01 B | USA |